Search - tctmd.com

Displaying 441 - 460 of 1165

Sort: Relevancy | Date

Myocarditis Risk Varies by COVID-19 Vaccine Type, Dosing Interval

News Daily News

Myocarditis Risk Varies by COVID-19 Vaccine Type, Dosing Interval

June 28, 2022

AHA/ACC Standardize Definitions for COVID-19 Complications

News Daily News

AHA/ACC Standardize Definitions for COVID-19 Complications

June 27, 2022

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

June 23, 2022

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

News Daily News

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

June 21, 2022

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

News Daily News

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Michael O'Riordan

June 17, 2022

Risking COVID-19 for Professional Gain? Spring’s In-Person Meetings in Hindsight

News Features

Risking COVID-19 for Professional Gain? Spring’s In-Person Meetings in Hindsight

Yael L. Maxwell

June 16, 2022

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

News Daily News

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

June 09, 2022

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

June 2022 News Roundup

News Opinion CV Team Dispatch

June 2022 News Roundup

June 01, 2022

Aficamten Safe, Effective for Up to 6 months in Obstructive HCM: REDWOOD-HCM OLE

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

May 31, 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

May 26, 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

May 25, 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

May 23, 2022

Dapagliflozin Boosts Health Status Across LVEF Range

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

May 23, 2022

Speech-Recognition Tool May Predict Worsening Congestion in HF

News Conference News ESC Heart Failure 2022

Speech-Recognition Tool May Predict Worsening Congestion in HF

May 22, 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

May 22, 2022

Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry

News Daily News

Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry

May 20, 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

Registry Data Hint at MACE Benefit with Renal Denervation

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.